Joseph Ahn

Associate Professor

  • 755 Citations
  • 16 h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Joseph Ahn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Hepacivirus Medicine & Life Sciences
Liver Transplantation Medicine & Life Sciences
Liver Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Hepatitis B Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

  • 755 Citations
  • 16 h-Index
  • 48 Article
  • 4 Review article
  • 1 Chapter

Response to Forrest et al

Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S. & Shah, V. H., Jan 1 2019, In : The American Journal of Gastroenterology. 114, 1, 1 p.

Research output: Contribution to journalArticle

59 Citations (Scopus)

ACG clinical guideline: Alcoholic liver disease

Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S. & Shah, V. H., Feb 1 2018, In : American Journal of Gastroenterology. 113, 2, p. 175-194 20 p.

Research output: Contribution to journalReview article

Alcoholic Liver Diseases
Alcoholic Hepatitis
Guidelines
Liver Diseases
Alcoholic Liver Cirrhosis
2 Citations (Scopus)

A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study

Lee, H. M., Ahn, J., Kim, W. R., Lim, J. K., Nguyen, M., Pan, C. Q., Kim, D., Mannalithara, A., Te, H., Trinh, H., Chu, D., Tran, T., Woog, J. & Lok, A. S., Jan 1 2018, (Accepted/In press) In : Digestive Diseases and Sciences.

Research output: Contribution to journalArticle

Chronic Hepatitis B
Fibrosis
entecavir
Hepatitis B e Antigens
DNA
4 Citations (Scopus)

Chronic Hepatitis C and Direct Acting Antivirals

Westerhoff, M. & Ahn, J., Jan 1 2018, (Accepted/In press) In : Surgical Pathology Clinics.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Hepacivirus
Antiviral Agents
End Stage Liver Disease
Therapeutics
1 Citation (Scopus)

Direct-acting antiviral regimens are safe and effective in the treatment of hepatitis C in simultaneous liver–kidney transplant recipients

Nookala, A. U., Crismale, J., Schiano, T., Te, H., Ahn, J., Robertazzi, S., Rodigas, C., Satoskar, R., Mandip, K. C., Hassan, M. & Smith, C., Mar 1 2018, In : Clinical Transplantation. 32, 3, e13198.

Research output: Contribution to journalArticle

Hepatitis C
Antiviral Agents
Transplants
Liver
Kidney